How many chronic myeloid leukemia patients who started a frontline second-generation tyrosine kinase inhibitor have to switch to a second-line treatment? A retrospective analysis from the monitoring registries of the italian medicines agency (AIFA)
| Image |  |
|---|---|
| Description | scientific article published on 22 April 2020 |
| Author/s |
author: Alessandra Iurlo Massimo Breccia Fabrizio Pane Pier Paolo Olimpieri |
| Publication date | April 22, 2020 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |